{
  "DOI": "10.1038/s41431-018-0095-5",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-018-0095-5",
  "alternative-id": [
    "95"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "22 May 2017"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "7 November 2017"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "19 December 2017"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "8 February 2018"
    },
    {
      "group": {
        "label": "Compliance with ethical standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors declare that they have no conflict of interest."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0003-2018-3679",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Pitini",
      "given": "Erica",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "De Vito",
      "given": "Corrado",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Marzuillo",
      "given": "Carolina",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "D’Andrea",
      "given": "Elvira",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Rosso",
      "given": "Annalisa",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Federici",
      "given": "Antonio",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-8357-2658",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Di Maria",
      "given": "Emilio",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Villari",
      "given": "Paolo",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2018,
        2,
        8
      ]
    ],
    "date-time": "2018-02-08T09:56:51Z",
    "timestamp": 1518083811000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        8,
        31
      ]
    ],
    "date-time": "2023-08-31T22:24:41Z",
    "timestamp": 1693520681000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        27
      ]
    ],
    "date-time": "2024-04-27T15:56:24Z",
    "timestamp": 1714233384350
  },
  "is-referenced-by-count": 46,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "5",
  "issued": {
    "date-parts": [
      [
        2018,
        2,
        8
      ]
    ]
  },
  "journal-issue": {
    "issue": "5",
    "published-print": {
      "date-parts": [
        [
          2018,
          5
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by-nc-nd/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2018,
            2,
            8
          ]
        ],
        "date-time": "2018-02-08T00:00:00Z",
        "timestamp": 1518048000000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/s41431-018-0095-5",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/s41431-018-0095-5.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/s41431-018-0095-5.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "605-615",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2018,
        2,
        8
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2018,
        2,
        8
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2018,
        5
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1097/GIM.0b013e3181f9ad55",
      "author": "MJ Khoury",
      "doi-asserted-by": "publisher",
      "first-page": "680",
      "journal-title": "Genet Med",
      "key": "95_CR1",
      "unstructured": "Khoury MJ, Coates RJ, Evans JP. Evidence-based classification of recommendations on use of genomic tests in clinical practice: dealing with insufficient evidence. Genet Med. 2010;12:680–3.",
      "volume": "12",
      "year": "2010"
    },
    {
      "DOI": "10.1093/qjmed/hct190",
      "author": "C Marzuillo",
      "doi-asserted-by": "publisher",
      "first-page": "93",
      "journal-title": "QJM",
      "key": "95_CR2",
      "unstructured": "Marzuillo C, De Vito C, D’Andrea E, Rosso A, Villari P. Predictive genetic testing for complex diseases: a public health perspective. QJM. 2014;107:93–97.",
      "volume": "107",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.amepre.2010.12.009",
      "author": "MJ Khoury",
      "doi-asserted-by": "publisher",
      "first-page": "486",
      "journal-title": "Am J Prev Med",
      "key": "95_CR3",
      "unstructured": "Khoury MJ, Bowen MS, Burke W, et al. Current priorities for public health practice in addressing the role of human genomics in improving population health. Am J Prev Med. 2011;40:486–93.",
      "volume": "40",
      "year": "2011"
    },
    {
      "author": "S Boccia",
      "first-page": "29",
      "journal-title": "Epidemiol Prev",
      "key": "95_CR4",
      "unstructured": "Boccia S, Federici A, Colotto M, Villari P. Implementation of Italian guidelines on public health genomics in Italy: a challenging policy of the NHS. Epidemiol Prev. 2014;38:29–34.",
      "volume": "38",
      "year": "2014"
    },
    {
      "key": "95_CR5",
      "unstructured": "Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0. The Cochrane Collaboration, 2011."
    },
    {
      "DOI": "10.1016/j.jclinepi.2009.06.006",
      "author": "A Liberati",
      "doi-asserted-by": "publisher",
      "first-page": "e1",
      "journal-title": "J Clin Epidemiol",
      "key": "95_CR6",
      "unstructured": "Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:e1–34. https://doi.org/10.1016/j.jclinepi.2009.06.006 .",
      "volume": "62",
      "year": "2009"
    },
    {
      "author": "JE Haddow",
      "first-page": "217",
      "key": "95_CR7",
      "unstructured": "Haddow JE, Palomaki GE. ACCE: a model process for evaluating data on emerging genetic tests. In: Khoury M, Little J, Burke W editors. Human genome epidemiology: a scientific foundation for using genetic information to improve health and prevent disease.. Oxford, UK: Oxford University Press; 2004. p. 217–33.",
      "volume-title": "Human genome epidemiology: a scientific foundation for using genetic information to improve health and prevent disease.",
      "year": "2004"
    },
    {
      "key": "95_CR8",
      "unstructured": "UK Genetic Testing Network. Testing criteria for molecular genetic tests. 2005. Available at http://ukgtn.nhs.uk/fileadmin/uploads/ukgtn/Documents/Resources/Library/Policies_Procedures/MKTesting%20Criteria%20Paper%202005.pdf . Accessed 26 Apr 2017."
    },
    {
      "DOI": "10.1038/sj.ejhg.5201867",
      "author": "M Kroese",
      "doi-asserted-by": "publisher",
      "first-page": "917",
      "journal-title": "Eur J Hum Genet",
      "key": "95_CR9",
      "unstructured": "Kroese M, Zimmern RL, Farndon P, Stewart F, Whittaker J. How can genetic tests be evaluated for clinical use? Experience of the UK Genetic Testing Network. Eur J Hum Genet. 2007;9:917–21.",
      "volume": "9",
      "year": "2007"
    },
    {
      "author": "UK Genetic Testing Network.",
      "key": "95_CR10",
      "unstructured": "UK Genetic Testing Network. First report of the UKGTN. Supporting genetic testing in the NHS. London, UK: UK Genetic Testing Network; 2008.",
      "volume-title": "First report of the UKGTN. Supporting genetic testing in the NHS",
      "year": "2008"
    },
    {
      "DOI": "10.1097/GIM.0b013e318184137c",
      "author": "SM Teutsch",
      "doi-asserted-by": "publisher",
      "first-page": "3",
      "journal-title": "Genet Med",
      "key": "95_CR11",
      "unstructured": "Teutsch SM, Bradley LA, Palomaki GE, et al. The evaluation of genomic applications in practice and prevention (EGAPP) initiative: methods of the EGAPP Working Group. Genet Med. 2009;1:3–14.",
      "volume": "1",
      "year": "2009"
    },
    {
      "DOI": "10.1038/gim.2012.106",
      "author": "DL Veenstra",
      "doi-asserted-by": "publisher",
      "first-page": "14",
      "journal-title": "Genet Med",
      "key": "95_CR12",
      "unstructured": "Veenstra DL, Piper M, Haddow JE, et al. Improving the efficiency and relevance of evidence-based recommendations in the era of whole-genome sequencing: an EGAPP methods update. Genet Med. 2013;1:14–24.",
      "volume": "1",
      "year": "2013"
    },
    {
      "author": "S Márquez Calderón",
      "key": "95_CR13",
      "unstructured": "Márquez Calderón S, Briones Pérez, de la Blanca E. Framework for the assessment of genetic testing in the Andalusian Public Health System. Seville, Andalusia: Andalusian Agency for Health Technology Assessment; 2006.",
      "volume-title": "Framework for the assessment of genetic testing in the Andalusian Public Health System",
      "year": "2006"
    },
    {
      "DOI": "10.1097/GIM.0b013e3180a6e9ef",
      "author": "JM Gudgeon",
      "doi-asserted-by": "publisher",
      "first-page": "473",
      "journal-title": "Genet Med",
      "key": "95_CR14",
      "unstructured": "Gudgeon JM, McClain MR, Palomaki GE, Williams MS. Rapid ACCE: experience with a rapid and structured approach for evaluating gene-based testing. Genet Med. 2007;7:473–8.",
      "volume": "7",
      "year": "2007"
    },
    {
      "author": "W Burke",
      "key": "95_CR15",
      "unstructured": "Burke W, Zimmern R. Moving beyond ACCE: an expanded framework for genetic test evaluation. Cambridge, UK: PHG Foundation; 2007.",
      "volume-title": "Moving beyond ACCE: an expanded framework for genetic test evaluation",
      "year": "2007"
    },
    {
      "author": "S Aretz",
      "key": "95_CR16",
      "unstructured": "Aretz S, Rautenstrauß B, Timmerman V. Indication criteria for genetic testing. Evaluation of validity and clinical utility. Munich, Germany: German Society of Human Genetics; 2008.",
      "volume-title": "Indication criteria for genetic testing. Evaluation of validity and clinical utility",
      "year": "2008"
    },
    {
      "DOI": "10.1038/ejhg.2010.85",
      "author": "J Schmidtke",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Eur J Hum Genet",
      "key": "95_CR17",
      "unstructured": "Schmidtke J, Cassiman JJ. The EuroGentest Clinical Utility Gene Cards. Eur J Hum Genet. 2010;24:1. https://doi.org/10.1038/ejhg.2010.85 .",
      "volume": "24",
      "year": "2010"
    },
    {
      "DOI": "10.1038/ejhg.2012.161",
      "author": "A Dierking",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Eur J Hum Genet",
      "key": "95_CR18",
      "unstructured": "Dierking A, Schmidtke J, Matthijs G, Cassiman JJ. The EuroGentest Clinical Utility Gene Cards continued. Eur J Hum Genet. 2013;21:1. https://doi.org/10.1038/ejhg.2012.161 .",
      "volume": "21",
      "year": "2013"
    },
    {
      "DOI": "10.1038/ejhg.2014.23",
      "author": "A Dierking",
      "doi-asserted-by": "publisher",
      "first-page": "1247",
      "journal-title": "Eur J Hum Genet",
      "key": "95_CR19",
      "unstructured": "Dierking A, Schmidtke J. The future of Clinical Utility Gene Cards in the context of next-generation sequencing diagnostic panels. Eur J Hum Genet. 2014;22:1247. https://doi.org/10.1038/ejhg.2014.23 .",
      "volume": "22",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s00439-009-0767-x",
      "author": "CF Wright",
      "doi-asserted-by": "publisher",
      "first-page": "125",
      "journal-title": "Hum Genet",
      "key": "95_CR20",
      "unstructured": "Wright CF, Kroese M. Evaluation of genetic tests for susceptibility to common complex diseases: why, when and how? Hum Genet. 2010;127:125–34.",
      "volume": "127",
      "year": "2010"
    },
    {
      "DOI": "10.1097/GIM.0b013e3181d2af04",
      "author": "N Calonge",
      "doi-asserted-by": "publisher",
      "first-page": "153",
      "journal-title": "Genet Med",
      "key": "95_CR21",
      "unstructured": "Calonge N, Green NS, Rinaldo P, et al. Committee report: method for evaluating conditions nominated for population-based screening of newborns and children. Genet Med. 2010;3:153–9.",
      "volume": "3",
      "year": "2010"
    },
    {
      "author": "F Sun",
      "key": "95_CR22",
      "unstructured": "Sun F, Bruening W, Erinoff E, Schoelles KM, ECRI Institute Evidence-based Practice Center. Addressing challenges in genetic test evaluation. Evaluation frameworks and assessment of analytic validity. Rockville, USA: Agency for Healthcare Research and Quality; 2011.",
      "volume-title": "Addressing challenges in genetic test evaluation. Evaluation frameworks and assessment of analytic validity",
      "year": "2011"
    },
    {
      "author": "WJ Canestaro",
      "first-page": "700",
      "journal-title": "J Manag Care Spec Pharm",
      "key": "95_CR23",
      "unstructured": "Canestaro WJ, Pritchard DE, Garrison LP, Dubois R, Veenstra DL. Improving the efficiency and quality of the value assessment process for companion diagnostic tests: The Companion test Assessment Tool (CAT). J Manag Care Spec Pharm. 2015;21:700–12.",
      "volume": "21",
      "year": "2015"
    },
    {
      "key": "95_CR24",
      "unstructured": "Medical Service Advisory Committee. Australian Government, Department of Health. Clinical Utility Card for heritable mutations which increase risk in [disease area]. 2016. Available at http://www.msac.gov.au/internet/msac/publishing.nsf/Content/9C7DCF1C2DD56CBECA25801000123C32/$File/CUC-proforma-assessment-genetic-testing.pdf Accessed 18 Apr 2017."
    },
    {
      "author": "Advisory Committee on New Predictive Genetic Technologies.",
      "key": "95_CR25",
      "unstructured": "Advisory Committee on New Predictive Genetic Technologies. Genetic Services in Ontario: Mapping the Future. Report of the Provincial Advisory Committee on New Predictive Genetic Technologies. Ontario, Canada: Advisory Committee on New Predictive Genetic Technologies; 2001.",
      "volume-title": "Genetic Services in Ontario: Mapping the Future. Report of the Provincial Advisory Committee on New Predictive Genetic Technologies",
      "year": "2001"
    },
    {
      "author": "I Blancquaert",
      "first-page": "309",
      "journal-title": "Eur J Hum Genet",
      "key": "95_CR26",
      "unstructured": "Blancquaert I, Bouchard L, Chikhaoui Y, Cleret, de Langavant G. Molecular genetics viewed from the Health Technology Assessment Perspective. Eur J Hum Genet. 2001;1:309–10. (abstract)",
      "volume": "1",
      "year": "2001"
    },
    {
      "author": "I Blancquaert",
      "first-page": "23",
      "key": "95_CR27",
      "unstructured": "Blancquaert I. Testing for BRCA: the Canadian experience. In: Kroese M, Elles R, Zimmern RL, editors. The Evaluation of Clinical Validity and Clinical Utility of Genetic Tests, Summary of an expert workshop, 26 and 27 June 2006. Cambridge, UK: PHG Foundation; 2007. p. 23–25.",
      "volume-title": "The Evaluation of Clinical Validity and Clinical Utility of Genetic Tests, Summary of an expert workshop, 26 and 27 June 2006",
      "year": "2007"
    },
    {
      "DOI": "10.1017/S0266462303000278",
      "author": "M Giacomini",
      "doi-asserted-by": "publisher",
      "first-page": "301",
      "journal-title": "Int J Technol Assess Health Care",
      "key": "95_CR28",
      "unstructured": "Giacomini M, Miller F, Browman G. Confronting the “gray zones” of technology assessment: evaluating genetic testing services for public insurance coverage in Canada. Int J Technol Assess Health Care. 2003;2:301–16.",
      "volume": "2",
      "year": "2003"
    },
    {
      "DOI": "10.2427/8653",
      "doi-asserted-by": "publisher",
      "key": "95_CR29",
      "unstructured": "Gutiérrez-Ibarluzea I Personalised Health Care, the need for reassessment. A HTA perspective far beyond cost-effectiveness. Ital J Public Health. 2012; https://doi.org/10.2427/8653 ."
    },
    {
      "DOI": "10.1177/0272989X12452341",
      "author": "T Merlin",
      "doi-asserted-by": "publisher",
      "first-page": "333",
      "journal-title": "Med Decis Mak",
      "key": "95_CR30",
      "unstructured": "Merlin T, Farah C, Schubert C, Mitchell A, Hiller JE, Ryan P. Assessing personalized medicines in Australia: a national framework for reviewing codependent technologies. Med Decis Mak. 2013;3:333–42.",
      "volume": "3",
      "year": "2013"
    },
    {
      "author": "N Fleeman",
      "first-page": "1",
      "journal-title": "Health Technol Assess",
      "key": "95_CR31",
      "unstructured": "Fleeman N, Martin Saborido C, Payne K, et al. The clinical effectiveness and cost-effectiveness of genotyping for CYP2D6 for the management of women with breast cancer treated with tamoxifen: a systematic review. Health Technol Assess. 2011;33:1–102.",
      "volume": "33",
      "year": "2011"
    },
    {
      "key": "95_CR32",
      "unstructured": "Allingham-Hawkins DJ, Lea A, Spock L, Levine S Hayes Genetic Test Evaluation (GTE) Program: Evidence-based evaluation of genetic tests. Inaugural Meeting of the Genomic Applications in Practice and Prevention Network. Ann Arbor, USA, 29-30 Oct 2009 (abstract)."
    },
    {
      "DOI": "10.2427/6348.",
      "doi-asserted-by": "publisher",
      "key": "95_CR33",
      "unstructured": "Betti S, Boccia A, Boccia S, et al. HTA of genetic testing for susceptibility to venous thromboembolism in Italiy. Ital J Public Health. 2012; https://doi.org/10.2427/6348."
    },
    {
      "DOI": "10.1136/bmj.322.7295.1174",
      "author": "V Goel",
      "doi-asserted-by": "publisher",
      "first-page": "1174",
      "journal-title": "BMJ",
      "key": "95_CR34",
      "unstructured": "Goel V. Appraising organised screening programmes for testing for genetic susceptibility to cancer. BMJ. 2001;7295:1174–8.",
      "volume": "7295",
      "year": "2001"
    },
    {
      "DOI": "10.1089/10906570152742245",
      "author": "W Burke",
      "doi-asserted-by": "publisher",
      "first-page": "201",
      "journal-title": "Genet Test",
      "key": "95_CR35",
      "unstructured": "Burke W, Coughlin SS, Lee NC, Weed DL, Khoury MJ. Application of population screening principles to genetic screening for adult-onset conditions. Genet Test. 2001;3:201–11.",
      "volume": "3",
      "year": "2001"
    },
    {
      "DOI": "10.1159/000272898",
      "author": "A Andermann",
      "doi-asserted-by": "publisher",
      "first-page": "9",
      "journal-title": "Public Health Genom",
      "key": "95_CR36",
      "unstructured": "Andermann A, Blancquaert I, Beauchamp S, Costea I. Guiding policy decisions for genetic screening: developing a systematic and transparent approach. Public Health Genom. 2011;1:9–16.",
      "volume": "1",
      "year": "2011"
    },
    {
      "DOI": "10.1258/jhsrp.2009.009084",
      "author": "A Andermann",
      "doi-asserted-by": "publisher",
      "first-page": "90",
      "journal-title": "J Health Serv Res Policy",
      "key": "95_CR37",
      "unstructured": "Andermann A, Blancquaert I, Déry V. Genetic screening: a conceptual framework for programs and policy-making. J Health Serv Res Policy. 2010;2:90–97.",
      "volume": "2",
      "year": "2010"
    },
    {
      "DOI": "10.1515/CCLM.2010.291",
      "author": "F Rousseau",
      "doi-asserted-by": "crossref",
      "first-page": "1397",
      "journal-title": "Clin Chem Lab Med",
      "key": "95_CR38",
      "unstructured": "Rousseau F, Lindsay C, Charland M, et al. Development and description of GETT: a genetic testing evidence tracking tool. Clin Chem Lab Med. 2010;10:1397–407.",
      "volume": "10",
      "year": "2010"
    },
    {
      "DOI": "10.1089/gtmb.2011.0177",
      "author": "J Hornberger",
      "doi-asserted-by": "publisher",
      "first-page": "605",
      "journal-title": "Genet Test Mol Biomark",
      "key": "95_CR39",
      "unstructured": "Hornberger J, Doberne J, Chien R. Laboratory-developed test--SynFRAME: an approach for assessing laboratory-developed tests synthesized from prior appraisal frameworks. Genet Test Mol Biomark. 2012;6:605–14.",
      "volume": "6",
      "year": "2012"
    },
    {
      "DOI": "10.1186/1472-6947-12-117",
      "author": "JS Lin",
      "doi-asserted-by": "publisher",
      "journal-title": "BMC Med Inform Decis Mak",
      "key": "95_CR40",
      "unstructured": "Lin JS, Thompson M, Goddard KA, Piper MA, Heneghan C, Whitlock EP. Evaluating genomic tests from bench to bedside: a practical framework. BMC Med Inform Decis Mak. 2012;12:117.",
      "volume": "12",
      "year": "2012"
    },
    {
      "DOI": "10.1586/14737159.2014.933075",
      "author": "FW Frueh",
      "doi-asserted-by": "publisher",
      "first-page": "777",
      "journal-title": "Expert Rev Mol Diagn",
      "key": "95_CR41",
      "unstructured": "Frueh FW, Quinn B. Molecular diagnostics clinical utility strategy: a six-part framework. Expert Rev Mol Diagn. 2014;14:777–86.",
      "volume": "14",
      "year": "2014"
    },
    {
      "author": "National Academies of Sciences, Engineering, and Medicine.",
      "key": "95_CR42",
      "unstructured": "National Academies of Sciences, Engineering, and Medicine. An evidence framework for genetic testing.. Washington, USA: The National Academies Press; 2017.",
      "volume-title": "An evidence framework for genetic testing.",
      "year": "2017"
    },
    {
      "key": "95_CR43",
      "unstructured": "Centers for Disease Control and prevention. First ACCE Review: Population-based Prenatal Screening for Cystic Fibrosis via CarrierTesting. 2002. Available at https://www.cdc.gov/genomics/gtesting/acce/acce.htm . Accessed 26 Apr 2017."
    },
    {
      "key": "95_CR44",
      "unstructured": "UK Genetic Testing Network website. Available at http://ukgtn.nhs.uk/find-a-test/gene-dossiers . Accessed 8 May 2017."
    },
    {
      "key": "95_CR45",
      "unstructured": "Evaluation of Genomic Applications in Practice and Prevention web site. Available at http://www.cdc.gov/egappreviews/ . Accessed 8 May 2017."
    },
    {
      "DOI": "10.1097/GIM.0b013e31815bf924",
      "author": "MR McClain",
      "doi-asserted-by": "publisher",
      "first-page": "89",
      "journal-title": "Genet Med",
      "key": "95_CR46",
      "unstructured": "McClain MR, Palomaki GE, Piper M, Haddow JE. A rapid-ACCE review of CYP2C9 and VKORC1 alleles testing to inform warfarin dosing in adults at elevated risk for thrombotic events to avoid serious bleeding. Genet Med. 2008;2:89–98.",
      "volume": "2",
      "year": "2008"
    },
    {
      "key": "95_CR47",
      "unstructured": "German Society of Human Genetics website. Available at http://www.gfhev.de/de/leitlinien/Diagnostik_LL.htm . Accessed 8 May 2017."
    },
    {
      "key": "95_CR48",
      "unstructured": "EuroGentest website. Available at http://www.eurogentest.org/index.php?id=668 . Accessed 21 Sept 2017."
    },
    {
      "key": "95_CR49",
      "unstructured": "European Journal of Human Genetics website. Available at http://www.nature.com/ejhg/archive/categ_genecard_012017.html?lang=en . Accessed 8 May 2017."
    },
    {
      "key": "95_CR50",
      "unstructured": "Advisory Committee on Heritable Disorders in Newborns and Children web site. Available at http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders . Accessed 26 Aug 2017."
    },
    {
      "key": "95_CR51",
      "unstructured": "Segal JB, Brotman DJ, Emadi A, et al. Outcomes of genetic testing in adults with a history of venous thromboembolism. Evidence Reports/Technology Assessments, No. 180. Rockville, USA: Agency for Healthcare Research and Quality. 2009."
    },
    {
      "key": "95_CR52",
      "unstructured": "Medical Service advisory committee website. Available at http://www.health.gov.au/internet/msac/publishing.nsf/Content/1411-public . Accessed 05 Apr 2017."
    },
    {
      "author": "J Tranchemontagne",
      "key": "95_CR53",
      "unstructured": "Tranchemontagne J, Boothroyd L, Blancquaert I. Contribution of BRCA1/2 Mutation Testing to Risk Assessment for Susceptibility to Breast and Ovarian Cancer. Monograph. Montréal, Canada: Agence d’évaluation des technologies et des modes d’intervention en santé; 2006.",
      "volume-title": "Contribution of BRCA1/2 Mutation Testing to Risk Assessment for Susceptibility to Breast and Ovarian Cancer. Monograph",
      "year": "2006"
    },
    {
      "key": "95_CR54",
      "unstructured": "Hayes Inc. Genetic test evaluation website. Available at https://www.hayesinc.com/hayes/publications/genetic-test-evaluation . Accessed 25 Apr 2017."
    },
    {
      "DOI": "10.1093/pubmed/fdm028",
      "author": "RL Zimmern",
      "doi-asserted-by": "publisher",
      "first-page": "246",
      "journal-title": "J Public Health",
      "key": "95_CR55",
      "unstructured": "Zimmern RL, Kroese M. The evaluation of genetic tests. J Public Health. 2007;29:246–50.",
      "volume": "29",
      "year": "2007"
    },
    {
      "DOI": "10.1097/01.gim.0000227935.26763.c6",
      "author": "SD Grosse",
      "doi-asserted-by": "publisher",
      "first-page": "448",
      "journal-title": "Genet Med",
      "key": "95_CR56",
      "unstructured": "Grosse SD, Khoury MJ. What is the clinical utility of genetic testing? Genet Med. 2006;8:448–50.",
      "volume": "8",
      "year": "2006"
    },
    {
      "DOI": "10.1038/ejhg.2017.10",
      "author": "JN Kohler",
      "doi-asserted-by": "publisher",
      "first-page": "662",
      "journal-title": "Eur J Hum Genet",
      "key": "95_CR57",
      "unstructured": "Kohler JN, Turbitt E, Biesecker BB. Personal utility in genomic testing: a systematic literature review. Eur J Hum Genet. 2017;25:662–8. https://doi.org/10.1038/ejhg.2017.10 .",
      "volume": "25",
      "year": "2017"
    },
    {
      "edition": "4th edn",
      "key": "95_CR58",
      "unstructured": "Drummond MF, Sculpher MJ, Claxton K, Torrance GW, Stoddart GL, editors. Methods for the economic evaluation of health care programmes. 4th edn. Oxford, UK: Oxford University Press; 2015.",
      "volume-title": "Methods for the economic evaluation of health care programmes",
      "year": "2015"
    },
    {
      "DOI": "10.1038/gim.2016.29",
      "author": "E D’Andrea",
      "doi-asserted-by": "publisher",
      "first-page": "1171",
      "journal-title": "Genet Med",
      "key": "95_CR59",
      "unstructured": "D’Andrea E, Marzuillo C, De Vito C, et al. Which BRCA genetic testing programs are ready for implementation in health care? A systematic review of economic evaluations. Genet Med. 2016;18:1171–80.",
      "volume": "18",
      "year": "2016"
    },
    {
      "key": "95_CR60",
      "unstructured": "NHS UKGTN Testing Criteria. Available at https://ukgtn.nhs.uk/fileadmin/uploads/ukgtn/Documents/Resources/Library/Policies_Procedures/Testing_Criteria_paper.pdf . Accessed 30 Oct 2017."
    },
    {
      "DOI": "10.1017/S0266462310001315",
      "author": "MP Gagnon",
      "doi-asserted-by": "publisher",
      "first-page": "31",
      "journal-title": "Int J Technol Assess Health Care",
      "key": "95_CR61",
      "unstructured": "Gagnon MP, Desmartis M, Lepage-Savary D, et al. Introducing patients’ and the public’s perspectives to health technology assessment: a systematic review of international experiences. Int J Technol Assess Health Care. 2011;1:31–42.",
      "volume": "1",
      "year": "2011"
    },
    {
      "key": "95_CR62",
      "unstructured": "HIScreenDiag Report Summary. Building a tool to evaluate and improve health investments in screening and diagnosis of disease. 2011. Available at http://cordis.europa.eu/result/rcn/56825_en.html . Accessed 8 May 2017."
    },
    {
      "key": "95_CR63",
      "unstructured": "EUnetHTA Joint Action 2, Work Package 8. HTA Core Model ® version 3.0. Available at https://www.htacoremodel.info/BrowseModel.aspx . Accessed 8 May 2017."
    },
    {
      "DOI": "10.1136/bmj.39489.470347.AD",
      "author": "GH Guyatt",
      "doi-asserted-by": "publisher",
      "first-page": "924",
      "journal-title": "BMJ",
      "key": "95_CR64",
      "unstructured": "Guyatt GH, Oxman AD, Vist GE, GRADE Working Group. et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924–6.",
      "volume": "336",
      "year": "2008"
    },
    {
      "author": "UK Genetic Testing Network.",
      "key": "95_CR65",
      "unstructured": "UK Genetic Testing Network. Fifth report of the UKGTN. Promoting gene testing together. London, UK: UK Genetic Testing Network; 2017.",
      "volume-title": "Fifth report of the UKGTN. Promoting gene testing together",
      "year": "2017"
    },
    {
      "DOI": "10.1038/ejhg.2015.229",
      "author": "G Matthijs",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Eur J Hum Genet",
      "key": "95_CR66",
      "unstructured": "Matthijs G, Dierking A, Schmidtke J. New EuroGentest/ESHG guidelines and a new clinical utility gene card format for NGS-based testing. Eur J Hum Genet. 2016;24:1. https://doi.org/10.1038/ejhg.2015.229 .",
      "volume": "24",
      "year": "2016"
    }
  ],
  "reference-count": 66,
  "references-count": 66,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-018-0095-5"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "How is genetic testing evaluated? A systematic review of the literature"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "26"
}